Uncategorised - European Medical Journal

Improving Large Language Models via Heart Team Simulation

Large language models (LLM) show promise in supporting clinical decision making, yet the influence of prompt design on performance in…

BCIS CHIP-PCI Score in Non-ST-Elevation Acute Coronary Syndrome

Complex, high-risk percutaneous coronary interventions (PCI) are increasingly being performed in patients with non-ST-elevation acute…

Impact on Reintervention and Amputation Rates Using Dual-Wire Re-Entry Balloon

Critical limb ischaemia (CLI) remains a major challenge in patients with peripheral artery disease (PAD),1 particularly when chronic total…

AI-Guided Risk Stratification in Aortic Stenosis

Traditional operative risk calculators, such as the European System for Cardiac Operative Risk Evaluation II (EuroSCORE II), may misclassify…

Age Matters: Comparing Outcomes of Patent Foramen Ovale Closure

Patent foramen ovale (PFO) is frequently identified in patients over 60 years old who present with cryptogenic stroke. However, whether PFO…

Mitral Annular Remodelling Following HighLife Transcatheter Mitral Valve Replacement

Transcatheter mitral valve replacement (TMVR) using the HighLife TMVR system has demonstrated feasibility, an acceptable safety profile…

HEART Score and Coronary Artery Disease in Patients with Non-ST Acute Coronary Syndrome

The history, ECG, age, risk factors, and troponin (HEART) score was developed as a rapid risk stratification tool. It has five components…

Invasive Biventricular Physiology and Response after Transcatheter Mitral Repair

Mitral valve transcatheter edge-to-edge repair (M-TEER) has transformed the treatment of mitral regurgitation (MR) for high-risk patients…

Outcomes of Functionally Guided Drug-Coated Balloon versus Drug-Eluting Stent Percutaneous Coronary Intervention

Percutaneous coronary intervention (PCI), guided by physiological lesion assessment, has been shown to improve clinical outcomes by…

Fecal Transplants Show Promise for Recurrent UTIs

A single fecal microbiota transplant (FMT) may offer a safe and effective alternative for treating recurrent urinary tract infections (rUTIs), according to a new proof-of-concept study in postmenopausal women.